GLP-1 Drug Market Expected to Hit USD 42.0 Billion by 2035 with a Remarkable 13.17% CAGR
Overview The GLP-1 Drug Market is rapidly emerging as one of the most transformative segments in the global pharmaceutical landscape, driven by the surging prevalence of type 2 diabetes, obesity, and metabolic disorders. Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for diabetes … Read more